CURE’s head & neck cancer page is a go-to resource for oncology news and updates in the world of head & neck cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in head & neck cancer.
June 9th 2023
From Shannen Doherty’s announcement that her breast cancer spread to her brain to a nonprofit being established in memory of the late YouTuber, Technoblade, here’s what’s happening in the oncology space this week.
June 2nd 2023
From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.
May 26th 2023
From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.
May 9th 2023
A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.
April 21st 2023
A patient with head and neck cancer highlights the importance of a strong support system throughout the time he was recovering from surgery.
April 18th 2023
HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.
April 12th 2023
Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.
April 10th 2023
I had what I thought was a canker sore that didn't heal. It ended up being cancer.
March 24th 2023
From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.
March 13th 2023
A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates.
March 8th 2023
After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.
March 6th 2023
How do survivors of head and neck cancer cope with drastic changes to one of the most visibly identifiable body parts — the head?
March 5th 2023
When I sit down with my paint brush, despite my cancer history, I don’t feel different anymore.
February 15th 2023
The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer.
February 9th 2023
Patients who are looking to quit smoking to better their survival and health outcomes should talk to their health care team about different methods to do so, an expert said.
January 25th 2023
Opdivo — even when given in a low dose — was shown to improve outcomes in patients with advanced head and neck squamous cell carcinoma, highlighting a new option for patients who cannot receive the full dose.
January 6th 2023
From tennis star Martina Navratilova’s two cancer diagnoses to First Lady Jill Biden undergoing Mohs surgery to have a suspicious lesion removed and musician deaths, here’s what’s happening in the cancer space this week.
January 4th 2023
A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.
November 11th 2022
From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.
October 11th 2022
NC410 plus Keytruda will be studied in a phase 1b/2 trial for patients with certain solid cancers that either did not respond to or have not been treated with an immunotherapy agent.
October 10th 2022
The FDA granted a fast track designation to an investigational drug alone and in combination with Keytruda to treat patients with HPV recurrent/metastatic head and neck squamous cell carcinoma.
September 29th 2022
Compared with surgery, active surveillance was just as effective and lowered anxiety levels in patients with low-risk papillary thyroid cancer.
September 27th 2022
The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.
September 20th 2022
Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.
July 20th 2022
The addition of Keytruda to chemoradiation, followed by maintenance Keytruda, did not lead to a statistically significant event-free survival benefit in patients with locally advanced head and neck squamous cell carcinoma.
July 15th 2022
The first patient enrolled onto a phase 1 trial has received TCMB07, an investigational drug, for the treatment of cachexia, a severe disorder that may occur in more than half of patients with advanced-stage cancer.
July 12th 2022
A clinical trial reviewing the safety and efficacy of a treatment regimen of enoblituzumab in combination with either retifanlimab or tebotelimab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has been stopped by the manufacturer of the cancer drugs.
June 29th 2022
Here is a roundup of cancer treatments that were approved by the FDA in the spring of 2022 that patients may have missed.
June 15th 2022
Although much has changed in the past two decades, more needs to be done to prepare cancer survivors for what happens after their treatments end.
June 4th 2022
Avasopasem manganese is the first drug that has been shown to reduce the incidence and severity of chemotherapy-related oral mucositis in patients with head and neck cancer, research showed.